Renata PLC (DSE:RENATA)
Bangladesh · Delayed Price · Currency is BDT 433.30
-5.60 (-1.28%)
At close: Jun 16, 2026
Renata Market Cap
Renata has a market cap or net worth of 49.7 billion as of June 16, 2026. Its market cap has decreased by -11.73% in one year.
Market Cap
49.70B
Enterprise Value
67.58B
Revenue
44.93B
Ranking
n/a
PE Ratio
18.20
Stock Price
433.30
Market Cap Chart
Since June 2, 2003, Renata's market cap has increased from 320.77M to 49.70B, an increase of 15,393.26%. That is a compound annual growth rate of 24.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 49.70B | 10.59% |
| Dec 30, 2025 | 44.94B | -38.31% |
| Dec 30, 2024 | 72.84B | -47.85% |
| Dec 27, 2023 | 139.69B | - |
| Dec 29, 2022 | 139.69B | -0.67% |
| Dec 30, 2021 | 140.64B | 30.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 191.21B |
| Beximco Pharmaceuticals PLC. | 55.85B |
| Unilever Consumer Care | 39.82B |
| Beacon Pharmaceuticals | 24.16B |
| The ACME Laboratories | 16.67B |
| Asiatic Laboratories | 15.27B |
| The IBN SINA Pharmaceutical Industry | 9.79B |
| Navana Pharmaceuticals | 7.79B |